Soleus Capital Management as of June 30, 2024
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 92 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tg Therapeutics (TGTX) | 5.7 | $65M | 3.6M | 17.79 | |
| Iovance Biotherapeutics (IOVA) | 5.3 | $61M | 7.5M | 8.02 | |
| United Therapeutics Corporation (UTHR) | 4.0 | $45M | 142k | 318.55 | |
| Nurix Therapeutics (NRIX) | 3.8 | $43M | 2.1M | 20.87 | |
| Edap Tms S A Sponsored Adr (EDAP) | 3.5 | $40M | 7.3M | 5.44 | |
| Terns Pharmaceuticals (TERN) | 3.0 | $34M | 4.9M | 6.81 | |
| Revolution Medicines (RVMD) | 2.9 | $33M | 856k | 38.81 | |
| SurModics (SRDX) | 2.9 | $33M | 782k | 42.04 | |
| Organogenesis Hldgs (ORGO) | 2.8 | $32M | 12M | 2.80 | |
| Jasper Therapeutics Com New (JSPR) | 2.6 | $29M | 1.3M | 22.70 | |
| Ideaya Biosciences (IDYA) | 2.1 | $24M | 694k | 35.11 | |
| Axogen (AXGN) | 2.1 | $24M | 3.3M | 7.24 | |
| Krystal Biotech (KRYS) | 2.0 | $23M | 126k | 183.64 | |
| Merus N V (MRUS) | 2.0 | $22M | 376k | 59.17 | |
| Penumbra (PEN) | 2.0 | $22M | 124k | 179.97 | |
| Essa Pharma Com New (EPIX) | 2.0 | $22M | 4.2M | 5.26 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.9 | $22M | 533k | 41.36 | |
| Celcuity (CELC) | 1.7 | $20M | 1.2M | 16.38 | |
| Inari Medical Ord (NARI) | 1.7 | $20M | 408k | 48.15 | |
| Beigene Sponsored Adr | 1.7 | $20M | 138k | 142.67 | |
| C4 Therapeutics Com Stk (CCCC) | 1.7 | $19M | 4.1M | 4.62 | |
| Castle Biosciences (CSTL) | 1.6 | $19M | 854k | 21.77 | |
| Neuropace (NPCE) | 1.6 | $18M | 2.4M | 7.56 | |
| Enliven Therapeutics (ELVN) | 1.6 | $18M | 769k | 23.37 | |
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $17M | 72k | 243.00 | |
| Syndax Pharmaceuticals (SNDX) | 1.5 | $17M | 827k | 20.53 | |
| Humana (HUM) | 1.5 | $17M | 44k | 373.65 | |
| GSK Sponsored Adr (GSK) | 1.4 | $16M | 415k | 38.50 | |
| Treace Med Concepts (TMCI) | 1.4 | $16M | 2.4M | 6.65 | |
| Vaxcyte (PCVX) | 1.2 | $14M | 185k | 75.51 | |
| 10x Genomics Cl A Com (TXG) | 1.2 | $14M | 719k | 19.45 | |
| Cg Oncology (CGON) | 1.2 | $13M | 425k | 31.57 | |
| Nuvalent Inc-a (NUVL) | 1.1 | $13M | 172k | 75.86 | |
| Evolus (EOLS) | 1.1 | $13M | 1.2M | 10.85 | |
| Enanta Pharmaceuticals (ENTA) | 0.9 | $10M | 800k | 12.97 | |
| Alector (ALEC) | 0.9 | $10M | 2.2M | 4.54 | |
| Keros Therapeutics (KROS) | 0.9 | $10M | 222k | 45.70 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.8 | $9.5M | 587k | 16.25 | |
| Arcellx Common Stock (ACLX) | 0.8 | $9.4M | 171k | 55.19 | |
| Biodesix (BDSX) | 0.8 | $9.4M | 6.1M | 1.53 | |
| Tango Therapeutics (TNGX) | 0.8 | $9.0M | 1.0M | 8.58 | |
| Orthopediatrics Corp. (KIDS) | 0.8 | $8.9M | 310k | 28.76 | |
| Rigel Pharmaceuticals (RIGL) | 0.8 | $8.6M | 1.0M | 8.22 | |
| Bausch Health Companies (BHC) | 0.7 | $8.4M | 1.2M | 6.97 | |
| Immunic (IMUX) | 0.7 | $8.1M | 7.3M | 1.11 | |
| Y Mabs Therapeutics (YMAB) | 0.7 | $7.8M | 648k | 12.08 | |
| Engene Holdings (ENGN) | 0.7 | $7.5M | 800k | 9.43 | |
| Pharvaris N V (PHVS) | 0.7 | $7.5M | 399k | 18.80 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 0.6 | $7.2M | 509k | 14.06 | |
| Dyne Therapeutics (DYN) | 0.6 | $7.1M | 201k | 35.29 | |
| CVRX (CVRX) | 0.6 | $7.0M | 587k | 11.99 | |
| Insmed Com Par $.01 (INSM) | 0.6 | $6.9M | 103k | 67.00 | |
| Hims & Hers Health Com Cl A (HIMS) | 0.6 | $6.7M | 333k | 20.19 | |
| Theratechnologies Com New (THTX) | 0.6 | $6.7M | 4.8M | 1.40 | |
| Immunovant (IMVT) | 0.6 | $6.7M | 252k | 26.40 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.5 | $6.2M | 1.7M | 3.62 | |
| Applied Therapeutics (APLT) | 0.5 | $5.9M | 1.3M | 4.67 | |
| Globus Med Cl A (GMED) | 0.5 | $5.9M | 86k | 68.49 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.5 | $5.8M | 54k | 106.73 | |
| Bioatla (BCAB) | 0.5 | $5.3M | 3.9M | 1.37 | |
| Erasca (ERAS) | 0.4 | $5.1M | 2.2M | 2.36 | |
| Verastem Com New (VSTM) | 0.4 | $5.0M | 1.7M | 2.98 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.4 | $4.5M | 1.2M | 3.60 | |
| Iradimed (IRMD) | 0.4 | $4.5M | 102k | 43.94 | |
| Miragen Therapeutics (VRDN) | 0.4 | $4.4M | 340k | 13.01 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $3.9M | 92k | 42.25 | |
| Insulet Corporation (PODD) | 0.3 | $3.8M | 19k | 201.80 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.3 | $3.7M | 200k | 18.67 | |
| Inspiremd (NSPR) | 0.3 | $3.4M | 1.4M | 2.50 | |
| Calcimedica Com New (CALC) | 0.3 | $3.1M | 784k | 3.96 | |
| The Beauty Health Company Com Cl A (SKIN) | 0.3 | $3.1M | 1.6M | 1.92 | |
| Sanofi Sponsored Adr (SNY) | 0.3 | $3.0M | 63k | 48.52 | |
| Fate Therapeutics (FATE) | 0.3 | $2.9M | 870k | 3.28 | |
| X4 Pharmaceuticals (XFOR) | 0.2 | $2.3M | 4.1M | 0.58 | |
| Olema Pharmaceuticals (OLMA) | 0.2 | $2.3M | 217k | 10.82 | |
| Janux Therapeutics (JANX) | 0.2 | $2.3M | 56k | 41.89 | |
| 4d Molecular Therapeutics In (FDMT) | 0.2 | $2.3M | 109k | 20.99 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.2 | $2.3M | 87k | 26.14 | |
| Cervomed (CRVO) | 0.2 | $2.2M | 127k | 17.12 | |
| Avita Therapeutics (RCEL) | 0.2 | $2.1M | 267k | 7.92 | |
| Novocure Ord Shs (NVCR) | 0.2 | $1.9M | 109k | 17.13 | |
| Inhibrx Biosciences (INBX) | 0.1 | $1.3M | 89k | 14.17 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $1.2M | 163k | 7.07 | |
| Adverum Biotechnologies Com New (ADVM) | 0.1 | $1.0M | 147k | 6.86 | |
| Establishment Labs Holdings Ord (ESTA) | 0.1 | $682k | 15k | 45.44 | |
| Orthofix Medical (OFIX) | 0.1 | $676k | 51k | 13.26 | |
| MiMedx (MDXG) | 0.1 | $574k | 83k | 6.93 | |
| Aadi Bioscience (AADI) | 0.0 | $487k | 333k | 1.46 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $476k | 24k | 20.24 | |
| Natera (NTRA) | 0.0 | $390k | 3.6k | 108.29 | |
| Io Biotech (IOBT) | 0.0 | $225k | 193k | 1.17 | |
| Xeris Pharmaceuticals (XERS) | 0.0 | $140k | 62k | 2.25 |
